SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,151.04 905.01
( 1.24%)

Global Indices

Nasdaq

52,520.99 122.42
(0.23%)

Dow Jones

7,766.26 22.66
(0.29%)

Hang Seng

64,627.45 673.26
(1.05%)

Nikkei 225

10,683.77 -2.77
(-0.03%)

Forex

USD-INR

95.08 -0.03
(-0.03%)

EUR-INR

106.01 -0.48
(-0.45%)

GBP-INR

126.67 -0.36
(-0.28%)

JPY-INR

0.60 0.00
(-0.36%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

42.71

1030.33

EPS(TTM)

Face Value()

Div & Yield %

20.47

0.06

Back

alembic ltd

Polyplex Corporation reports consolidated net profit of Rs 91.03 crore in the June 2026 quarter

Aug 12,2026

Net profit of Polyplex Corporation reported to Rs 91.03 crore in the quarter ended June 2026 as against net loss of Rs 19.31 crore during the previous quarter ended June 2025. Sales rose 29.62% to Rs 2253.62 crore in the quarter ended June 2026 as against Rs 1738.67 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	2253.62	1738.67	30
OPM %	13.15	-0.04	-
PBDT	305.00	15.07	1924
PBT	210.65	-70.60	LP
NP	91.03	-19.31	LP

74,151.04 905.01 ( 1.24%)

52,520.99 122.42 (0.23%)

7,766.26 22.66 (0.29%)

64,627.45 673.26 (1.05%)

10,683.77 -2.77 (-0.03%)

95.08 -0.03 (-0.03%)

106.01 -0.48 (-0.45%)

126.67 -0.36 (-0.28%)

0.60 0.00 (-0.36%)